arrow
M

Milena Čavić

institute for oncology and radiology of serbia
H指数:18
被引数:1,175

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pt(II) complexes with N,O-chelating Schiff base ligands: synthesis, spectroscopic characterization, biomolecular binding, and cytotoxicity

Pt(II)配合物与N,O-螯合Schiff碱配体:合成、光谱表征、生物分子结合及细胞毒性

2026-09-240
PRE
Genetic Landscape of Lynch Syndrome in a High-Risk Serbian Cohort: Predominance of MLH1 Variants and Implications for Risk-Based Testing

林奇综合征在塞尔维亚高风险队列中的遗传景观:MLH1变异的主导地位及其对基于风险检测的影响

2026-07-260
OA
Advances in Lung Cancer Basic and Translational Research in 2025 – Overview and Perspectives Focusing on NSCLC

2025年肺癌基础与转化研究进展——聚焦NSCLC的概述与展望

2025-06-030
PRE
Lung Cancer Screening Program Quality Indicators—Review and Recommendations: An International Association for the Study of Lung Cancer Delphi Process Study

肺癌筛查项目质量指标—综述与建议:一项国际肺癌研究协会德尔菲流程研究

2025-01-240
OAAI
Response to the Letters to the Editor by Jing Peng and Colleagues and by Lauren C Leiman Regarding the Manuscript Terminology Issues in Screening and Early Detection of Lung Cancer-International Association for the Study of Lung Cancer Early Detection and Screening Committee Expert Group Recommendations

对Jing Peng及其同事以及Lauren C Leiman关于肺癌筛查和早期检测中术语问题的手稿的致编辑信的回应—国际肺癌研究协会早期检测和筛查委员会专家小组建议

2025-01-010
PRE
Two Decades of Progress in Personalized Medicine of Colorectal Cancer in Serbia-Insights from the Institute for Oncology and Radiology of Serbia
2024-10-080
OAAI
Employing widening funds to address inequity in cancer research example of the STEPUPIORS collaborative rectal cancer project
2024-03-220
PRE